{"text": "                                                                               Wednesday                                                                                                      11\r\nDaily Nation! November 28, 2001\r\n                                                                                                                                             New mode\r\n                                                                                                                                             to assess\r\n                                                                                                                                             Aids drugs\r\n                                                                                                                                                                 LONDON\r\n                                                                                                                                                        tiveness and prevent drug resistance.\r\n                                                                                                                                                         cientists in the United States have devel-\r\n                                                                                                                                             S          oped a quick method to test anti-Aids\r\n                                                                                                                                                       treatments that could improve their effec-\r\n                                                                                                                                                Until now, doctors were unable to determine\r\n                                                                                                                                             whether a particular combination of drugs was\r\n                                                                                                                                             fighting HIV until four to eight weeks after the\r\n                                                                                                                                             treatment began.\r\n                                                                                                                                                But scientists at the National Institute of\r\n                                                                                                                                             Allergy and Infectious Diseases (NIAID) and the\r\n                                                                                                                                             National Cancer Institute (NCI). can now tell if\r\n                                                                                                                                             drugs are working in the first week.                   \"\r\n                                                                                                                                                \"We now have a quick; simple and direct way of\r\n                                                                                                                                             telling if the drugs are working,\" said Michael\r\n                                                                                                                                             Polis, an infectious disease specialist at NIAID.\r\n                                                                                                                                                 \"In addition to heading off mv drug resistance,\r\n                                                                                                                            oto Peter arun    this approach might also avoid exposing patients\r\n                                                                                                                                              to the toxicities of antiretroviral drugs that aren't\r\n  ANTICIPATION: Kilaikaon with his family - father Mr lerionka ole Mampalu, left, and mother Noorsalaash Enole, holding little sister         effective for them,\" he.added in a statement.\r\n  Tatiyia ole Mampalu. On the right is Dr Priscillah Santau Migiro.                                                                             Scientists usually determine how well drugs are\r\n                                                                                                                                             working by measuring the amount of the virus in\r\n                     Hope for child of two worlds                                                                                            the blood, or viral load, four to eight weeks after\r\n                                                                                                                                             treatment started.\r\n                                                                                                                                                Polis and his team, whose research is reported\r\n                                                                                                                                             in The Lancet medical journal, discovered that if a\r\n         Wo weeks ago, we highlighted the plight of Kilaikon ole .     free bed. Various tests will be done at the hospital to determine     patient's viral load had dropped 50-fold or more\r\n                                                                                                                                             by the sixth day of treatment, they had a good\r\n   T      Mampalu, an eight\u00b7year\u00b7old intersex child from Narok.        the child's dominant gender and to gauge whether surgery will         chance of long-term success with the treatment.\r\n            Like all the features in your favourite Wednesday family   help.                                                                    The test is no guarantee a person will get better,\r\n            magazine, Kilaikon's story touched many readers.     One      Kilaikon, travelled with his parents to Nairobi last week, and      but it predicted the outcome of the therapy in 95\r\n                                                                       met with Dr Migiro. He is already at the Gertrudes hospital.           per cent of cases.\u00b7                            . \".\r\n   of these is Dr Priscillah Santau Migiro, a member of the Kenya                                                                                About 17 different anti-retroviral drugs are\r\n   Paediatricians Association, who has offered to examine Kilaikon       Kilaikon, who has both male and female reproductive organs,          used in different combinations to fight the virus\r\n   and recommend the best course of action.                            seemed .to have overcome some of his shyness, probably in              that causes AIDS. The finding could improve the\r\n                                                                       anticipation of finally knowing where he belongs.                      use of the current crop of drugs until better thera-\r\n     Getrude's Garden Children's Hospital has offered Kilaikon a                                                                              pies are developed.\u00b7                      (Reuters)\r\nPage \f\r\n\r\n\r\n-------------------Trial Version-----------------------\r\n\r\nConvert PDF to Text Desktop Software.\r\n\r\nCopyright Convertpdftotext.net 2014.\r\n\r\nTo remove these lines, please activate your software from http://www.convertpdftotext.net/buynow.htm\r\n\r\n-------------------------------------------------------"}